Pharmacopeia
FENTANYL
Core pharmacology
- Class Group
Opiate Analgesic
- Introduction
Tertiary amine which is a synthetic phenylpiperidine derivative
- Indications Uses
1. to provide the analgesic component in general anaesthesia
2. in combination with a major tranquillizer to produce neuroleptanalgesia
3. to provide analgesia during labour when regional anaesthesia is not in
use
4. as an agent used for patient-controlled analgesia
5. in premedication and
6. for palliative care- Presentation
colourless solution 50mcg/ml, TDpatch (25mcg-100mcg/hr) and as lozenges
- Main Action
μ receptor agonist
- Mechanism of action
Binds primarily to inhibitory G-protein-coupled μ-opioid receptors → inhibits adenylyl cyclase → ↓ cAMP → opens K+ channels and inhibits presynaptic voltage-gated Ca2+ channels → hyperpolarisation and ↓ neurotransmitter release
- Physiological effects
inhibitory action,
modulating the pain response to produce analgesia.less likely to ppt histamine release
norad& serotonin axn, excitatory centrally- Absorption
IV/IM/TD. BA PO 30%SL50%skin>90%
onset IM.: 7-8 mins; IV imm; TD 6 hrs
duration IM:1-2 hrs; IV:0.5-1hr; TD 12hrs- Distribution
relative lipid sol 500
Rapid redistribution
pKa 8.4(10% union)- Protein binding
prot bind 80-85%
- Volume of distribution
Mod Vd 4-6L/kg
- Metabolism
Slow Hepatic, primarily via CYP3A4clearance
- Excretion
excretion Urine 75%
- Half-life
half life I.V.: 2-4 hours, prolonged context sensitive half time
- Special Points
- Incompatible with thiopental
- Dialysis - unknown
- Route And Dose
Bolus: 1-2 mcg/kg
inf: 1-2 mcg/kg/hr(relative potency 50-100)
- Adverse Effects Toxicity
Respiratory depression including postoperative recurrence. Bradycardia. Chest-wall rigidity. Nausea and vomiting. Dependence. Decreased gastrointestinal motility.